On the impact of different approaches to classify age-related macular degeneration: Results from the German AugUR study

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Brandl, Caroline ^a,b   Zimmermann, Martina E ^a   Günther, Felix ^c   Barth, Teresa ^b   Olden, Matthias ^a   Schelter, Sabine C ^a,b   Kronenberg, Florian ^d   Loss, Julika ^a   Küchenhoff, Helmut ^c   Helbig, Horst ^b   Weber, Bernhard H F ^a   Stark, Klaus J ^a   Heid, Iris M ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CLASSIFICATION; FEMALE; GERMANY; HUMAN; MACULAR DEGENERATION; MALE; PATHOLOGY; PREVALENCE; RETINA; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; GERMANY; HUMANS; MACULAR DEGENERATION; MALE; PREVALENCE; RETINA; RISK FACTORS;

EID: 85048213421     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-26629-5     Document Type: Article

References (24)

1. Augood, C. A. et al. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Archives of ophthalmology 124, 529-535 (2006).
2. Lim, L. S., Mitchell, P., Seddon, J. M., Holz, F. G. & Wong, T. Y. Age-related macular degeneration. Lancet 379, 1728-1738 (2012).
3. Rosenfeld, P. J. et al. Ranibizumab for neovascular age-related macular degeneration. The New England journal of medicine 355, 1419-1431 (2006).
4. Rosenfeld, P. J. Bevacizumab versus ranibizumab for AMD. The New England journal of medicine 364, 1966-1967 (2011).
5. Klein, R. et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 98, 1128-1134 (1991).
6. Klaver, C. C. et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Investigative ophthalmology & visual science 42, 2237-2241 (2001).
7. Davis, M. D. et al. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Archives of ophthalmology 123, 1484-1498 (2005).
8. Ferris, F. L. et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Archives of ophthalmology 123, 1570-1574 (2005).
9. Ferris, F. L. 3rd. et al. Clinical classification of age-related macular degeneration. Ophthalmology 120, 844-851 (2013).
10. Klein, R. et al. Harmonizing the classification of age-related macular degeneration in the three-continent AMD consortium. Ophthalmic epidemiology 21, 14-23 (2014).
11. Brandl, C. et al. Features of Age-Related Macular Degeneration in the General Adults and Their Dependency on Age, Sex, and Smoking: Results from the German KORA Study. PloS one 11, e0167181 (2016).
12. Wolfram, C. P. N. Weißbuch zur Situation der ophthalmologichen Versorgung in Deutschland, http://www.dog.org/wp-content/uploads/2013/03/DOG-Weibuch-2012-fin.pdf (2012).
13. Korb, C. A. et al. Prevalence of age-related macular degeneration in a large European cohort: results from the population-based Gutenberg Health Study. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 252, 1403-1411 (2014).
14. Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. The Lancet. Global health 2, e106-116 (2014).
15. Stark, K. et al. The German AugUR study: study protocol of a prospective study to investigate chronic diseases in the elderly. BMC geriatrics 15, 130 (2015).
16. Leitritz, M. A. et al. [Development and first results of fast and cost-effective examination methods for an ophthalmological screening within the National Cohort]. Klinische Monatsblatter fur Augenheilkunde 230, 1238-1246 (2013).
17. Liew, G., Joachim, N., Mitchell, P., Burlutsky, G. & Wang, J. J. Validating the AREDS Simplified Severity Scale of Age-Related Macular Degeneration with 5- and 10-Year Incident Data in a Population-Based Sample. Ophthalmology 123, 1874-1878 (2016).
18. Fleiss, J. L. & Cohen, J. Equivalence of Weighted Kappa and Intraclass Correlation Coefficient as Measures of Reliability. Educ Psychol Meas 33, 613-619 (1973).
19. Klein, R., Klein, B. E. & Linton, K. L. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99, 933-943 (1992).
20. Mitchell, P., Smith, W., Attebo, K. & Wang, J. J. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102, 1450-1460 (1995).
21. Jonasson, F. et al. Prevalence of age-related macular degeneration in old persons: Age, Gene/environment Susceptibility Reykjavik Study. Ophthalmology 118, 825-830 (2011).
22. Vingerling, J. R. et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102, 205-210 (1995).
23. Wilde, C. et al. Prevalence of age-related macular degeneration in an elderly UK Caucasian population-The Bridlington Eye Assessment Project: a cross-sectional study. Eye. https://doi.org/10.1038/eye.2017.30 (2017).
24. Akuffo, K. O. et al. Prevalence of age-related macular degeneration in the Republic of Ireland. The British journal of ophthalmology 99, 1037-1044 (2015).